The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with NRG1 rearrangements Meeting Abstract
| Authors: | Odintsov, I.; Gladstone, E.; Sisso, W. J.; Delasos, L.; Lui, A. J. W.; Sisso, E. M.; Vojnic, M.; Khodos, I.; Mattar, M. S.; de Stanchina, E.; Plessinger, D.; Leland, S. M.; Ladanyi, M.; Somwar, R. |
| Abstract Title: | The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with NRG1 rearrangements |
| Meeting Title: | 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 138 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2020 Oct 24-25 |
| Meeting Location: | Virtual |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | S15 |
| End Page: | S16 |
| Language: | English |
| ACCESSION: | WOS:000582839900033 |
| PROVIDER: | wos |
| DOI: | 10.1016/s0959-8049(20)31105-9 |
| Notes: | Meeting abstract: 31 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
